Postcatheterization femoral artery pseudoaneurysms: Therapeutic options. A case-controlled study  by Heis, Hussein A. et al.
i n t e r n a t i o n a l j o u r n a l o f s u r g e r y 6 ( 2 0 0 8 ) 2 1 4 – 2 1 9www. the i j s . comPostcatheterization femoral artery pseudoaneurysms:
Therapeutic options. A case-controlled studyHussein A. Heisa, Kamal E. Bani-Hania,*, Mwaffaq A. Elheisb, Rami J. Yaghana,
Bayan K. Bani-Hania
aDepartment of Surgery, King Abdullah University Hospital, Faculty of Medicine, Jordan University of Science and Technology,
P.O. Box 3030, Irbid 22110, Jordan
bDepartment of Radiology, King Abdullah University Hospital, Faculty of Medicine, Jordan University of Science and Technology,
Irbid, Jordana r t i c l e i n f o
Article history:
Received 11 November 2007
Received in revised form
29 February 2008
Accepted 12 March 2008





Postcatheterization* Corresponding author. Tel.: þ962 79 550001
E-mail address: banihani60@yahoo.com (
1743-9191/$ – see front matter ª 2008 Surgic
doi:10.1016/j.ijsu.2008.03.006a b s t r a c t
Objectives: Postcatheterization femoral artery pseudoaneurysm is a troublesome complica-
tion following percutaneous canulations of the femoral artery. Both diagnostic and thera-
peutic options in the management of these pseudoaneurysms have changed dramatically,
with surgery being required only rarely. We aimed to perform a comprehensive review of
our experience, techniques and results in treating postcatheterization femoral artery
pseudoaneurysms.
Methods: A retrospective study of all patients presenting with local complications following
invasive percutaneous femoral artery canulations over a five-year period was performed.
Physical examination with color Doppler ultrasound analysis identified 29 femoral artery
pseudoaneurysms. Surgery, duplex-guided compression, and thrombin injection were
the main therapeutic options.
Results: Fourteen cases of femoral artery pseudoaneurysms were treated by duplex-guided
compression obliteration with a 78.5% success rate. Four patients had spontaneous throm-
bosis of their pseudoaneurysms. Five patients underwent percutaneous thrombin injec-
tion. Six patients had conventional surgery. Three cases failed duplex-guided
compression: one closed with thrombin injection, and two were repaired surgically. Fol-
low-up US showed no recurrent pseudoaneurysms for patients who underwent successful
duplex-guided compression.
Conclusion: Despite the voluminous data in the literature of treating postcatheterization fem-
oral artery pseudoaneurysms by thrombin guided injection, as a quick and effectivemethod
of therapy, with infrequent failures and complications, our study confirms the clinical use-
fulness of duplex-guided compression in the management of these pseudoaneurysms. The
possibility of spontaneous thrombosis of small pseudoaneurysms is emphasized.
ª 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction artery diseases and peripheral vascular diseases, the fre-As the number of arteriographies rises exponentially both for
diagnostic purposes and as a treatment modality in coronary5; fax: þ962 2 7095010.
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torically, the incidence of a false aneurysm after arterial
catheterization was approximately 0.1%.6,7 However, recented by Elsevier Ltd. All rights reserved.
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false aneurysms from 0.2% to 9%.8,9 Femoral artery pseudoa-
neurysms (FAPs) requiring repair were seen in 1.1% of patients
who underwent cardiac catheterization for diagnostic pur-
poses and in 4.7% of patients after cardiac interventional pro-
cedures.10 FAPs occur in 0.1–0.2% of diagnostic angiograms
and in 0.8–2.2% of cases following peripheral interventional
procedures.3,6 Postcatheterization complications include
bleeding, arterial thrombosis, distal embolization, arteriove-
nous fistula and false aneurysm formation. Early reports on
the natural history of arterial pseudoaneurysms warned of
the potential for distal embolization, expansion, or cata-
strophic rupture,2,11,12 and recent reports have added persis-
tent pain and compression neuropathy as associated
morbidities.1,13,14
Clinically suspected FAP can easily be confirmed by color
Doppler ultrasonography.15–17 Surgical repair has been the tra-
ditional treatment.16 We now knowwith certainty that if such
lesions are left alone, spontaneous thrombosis may occur in
a significant number, particularly the small ones, and espe-
cially in patients not receiving anticoagulant therapy.5,15,18
Less invasive treatment options such as duplex-guided com-
pression and percutaneous thrombin injection into the lumen
of such pseudoaneurysms are currently considered the treat-
ment of choice.1,3–5,12,13 Endoluminal vascular repair with cov-
ered stents was reported as an alternative approach.15,18
Herein we report our experience with 29 cases of postca-
theterization FAPs, focusing on the use of various closure
techniques (duplex-ultrasound-guided compression, throm-
bin injection, and surgery).We aimed to present a comprehen-
sive review of our experience in the management of FAP,
mainly duplex-guided compression despite the current treat-
ment of these lesions with thrombin guided injection.2. Patients and methods
From June 2001 to September 2006, the hospital records of
8360 patients who had coronary or peripheral angiography
and angioplasty were reviewed. All complications related to
femoral puncture sites such as a bruit, hematoma, pulsatile
hematoma, or marked pain or tenderness were studied. A
color Doppler ultrasound analysis evaluated the presence of
pseudoaneurysm or other complications, such as arteriove-
nous fistula. The clinical diagnosis in our cases was based
on the presence of groin hematoma, and a pulsating mass.
Color Doppler ultrasound confirmed the diagnosis in all our
cases. The status of the injured vessel, the pseudoaneurysm,
and the connecting tract are displayed in real time as a two-
dimensional image. Criteria used to diagnose a pseudoaneur-
ysm included swirling color flow in a mass separate from the
underlying artery, color flow signal in a track leading from the
artery to the mass consistent with a pseudoaneurysm neck
and a to-and-fro Doppler waveform in the pseudoaneurysm
neck (a retrograde flow out of the pseudoaneurysm in dias-
tole).12–14 Twenty-nine patients were found as having FAPs.
The pseudoaneurysm vessel of origin was the common femo-
ral artery (CFA) in 21 patients, the superficial femoral artery
(SFA) in five patients, and in the remaining three patients
the origin could not be determined. Although there was nospecific treatment according to the different sites of FAP; the
six FAPs which were treated with surgery were 5 related to
the CFA and one related to the SFA; the 14 FAPs which were
treated with compression therapy were 12 related to the CFA
and two related to the SFA; the five FAPs which were treated
with thrombin injection, three were related to CFA and two
related to the SFA; and in the remaining four FAPs with spon-
taneous thrombosis, one was related to CFA and in three the
origin of the FAP was not determined. We applied the avail-
able treatment regardless of the site of origin and the volume
of the pseudoaneurysm, and we applied thrombin injection in
the last five cases.
At diagnosis, 14 patients received anticoagulation therapy
(LMWH) and nine received antiplatelet therapy (clopidogrel),
and none of the remaining six patients received anticoagula-
tion or antiplatelet therapy. We resume therapy by using clo-
pidogrel when indicated. Four patients had spontaneous
thrombosis of their pseudoaneurysms in the interval between
discovery and treatment. These pseudoaneurysms were less
than 2 cm in diameter, and neither anticoagulation nor antith-
rombotics were given in these four cases. Six patients under-
went conventional surgery, 14 were referred for duplex-
guided compression, and five patients for thrombin injection
as the initial and primary therapy. Actually at our hospital,
US-guided manual compression or percutaneous injection of
thrombin into a non complicated FAP was considered to be
the primary therapy. Surgery was considered for FAPs associ-
ated with active thigh bleeding from rupture in two patients,
local ischemic skin necrosis in one patient, suspicion of infec-
tion or groin abscess in two patients, and in one patient with
a large FAP with a wide ‘‘neck’’.
US-guided manual compression was performed by using
the technique of Fellmeth et al.12 The puncture site was
scanned with a variety of transducers ranging from 3.5 to
7.0 MHz. to determine the anatomy of the pseudoaneurysm.
The relationship of the flow lumen to the underlying pseudoa-
neurysm neck and artery was delineated. The soft tissues sur-
rounding the pseudoaneurysm were searched for evidence of
an arteriovenous fistula or of multiple interconnecting pseu-
doaneurysm lobes. After written informed consent was
obtained, the transducer was oriented to demonstrate the
pseudoaneurysm neck to the best advantage. Manual com-
pression was applied to the neck for 10–20 min periods to
completely arrest flow into the pseudoaneurysm. Brief inter-
mittent release between cycles was performed to assess pseu-
doaneurysm thrombosis, or to reposition the transducer.
Compression was continued until the pseudoaneurysm
achieved thrombosis or until patient or operator fatigue
compelled termination. Conscious sedation was employed
by using intravenous injections of 1–2 mg midazolam hydro-
chloride, and local anesthesia if needed.
US-guided thrombin injection was given by using the tech-
nique described by Kang et al.13 With transducers ranging
from a 5.0 to 7.5-MHz linear-array or a curved linear-array
transducer, the local anatomy was determined as previously
mentioned, with patent artery and vein. The needle was pre-
loadedwith human thrombin (500 U/mL); the freeze-dried hu-
man thrombin was reconstituted with the calcium chloride
solution. The needle was placed into that portion of the flow
lumen where the direction of flow was away from the
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men, 0.1–0.3 mL (100–300 U) of thrombin was injected over
3–5 s. Color Doppler USmonitored the development of throm-
bosis. In cases inwhich therewas partial thrombosis, a second
injection of 0.1–0.3 mL (100–300 U) was given into the remain-
ing flow lumen, with or without needle repositioning. The pa-
tient lay in bed with the affected leg straight for 4–6 h, with
frequent groin and foot pulse examinations in both methods.
The character of the dorsalis pedis and posterior tibialis arte-
rial pulses was documented prior to, during, and after both
procedures. Follow-up color Doppler US was performed
24–72 h post compression and thrombin procedures; a com-
plete thrombosis of the flow lumen defined successful proce-
dure. No percutaneous closure devices were used in any of our
patients.3. Results
During the study, 34 groin hematomas were identified.
Twenty-nine FAPs were diagnosed, but no arteriovenous fis-
tula was seen. Gender distribution was 19 (65.5%) males and
10 (34.5%) females, with a mean age of 58 years (range
34–72). The locations of the FAPs in the 10 female patients
were seven CFA and three SFA, while their locations in the
19 males were 14 CFA, two SFA, and in the remaining three
patients the location of the FAPs could not be determined.
Six of our patients were diabetics and five were hyperten-
sive. None of the patients was denied treatment for their
FAP due to medical history. Based on a mean rate of 1350 an-
nual coronary procedures and a mean of 300 peripheral diag-
nostic and procedural angiograms annually, we calculated
that the incidence of FAP was 0.26% and 0.09%, respectively,
with a total incidence of 0.35%.
Each of our patients had one pseudoaneurysm, which was
on the right side except one in the left. The time interval be-
tween insult and diagnosis ranged from within one week to
three weeks. These 29 pseudoaneurysms were developed af-
ter arterial catheterization performed for diagnostic angio-
gram in two cases, endovascular procedures in 25 cases, and
insertion of an intraaortic balloon pump in two cases. Cathe-
ter size ranged from 6 to 9.5 F; larger sizes were used for bal-
loon pump assistance. The FAP geometry and position in
relation to the artery, along with the volume of FAP, length
andwidth of the FAP neckwere documented before the proce-
dures. Pseudoaneurysm size ranged from 2.0 to 5.5 cm inmax-
imum diameter. The FAPs were not selected to one treatment
based solely on the diameter. At the beginning of the study,we
were unfamiliar with compression, and thrombin injection
therapy was not available at our institute; six patients were
operated upon to close the FAPs. During the study period,
four cases thrombosed spontaneously, and their size was
less than 2 cm in diameter. Ultrasound-guided compression
obliteration was the primary mode of treatment in 14 cases,
and was successful in 11 patients (78.5%) of the cases. Com-
pression time averaged 35 min with a range of 20–45 min,
and compression intervals of 10 min were used. Successful
treatment required from one to three sessions (one session
was defined as a series of compression attempts during one
visit). Eight patients had successful compression with onesession, two patients required two sessions, and one patient
needed three sessions to achieve successful compression.
Three patients were failed thrombosis, due to short and
wide neck in two cases and anticoagulation after valve re-
placement and could not tolerate its reversal in one patient.
These three failed cases were one thrombosed with thrombin
injection and two repaired surgically. The number of patients
in our study was too small to demonstrate a significant differ-
ence between patients receiving or not receiving anticoagu-
lants, although compression time was much longer in
patients taking anticoagulants. Owing to the numerous re-
ports on the successful use of percutaneous thrombin injec-
tion to treat iatrogenic FAP,13,19 we adopted this method
more recently and successfully treated five cases primarily,
and one case after failure of compression obliteration. Four
patients required a single needle pass and a single thrombin
injection. Two patients had only partial thrombosis of the
flow lumen after the first injection and required a second in-
jection. The injection of thrombin causes thrombosis to occur
extremely quickly. There were no complications as a result of
the procedure. In all cases, US showed that the femoral artery
and veinwere patent immediately and 24 h after the injection.
The strength of the foot pulses was unchanged after injection
in all cases.
All patients were rescanned 24–72 h after successful
thrombosis of the FAP and they remained thrombosed. No
complications attributable to duplex-guided compression or
thrombin injection were noted. Ankle brachial indices were
unchanged for all patients from pre-treatment to post-
treatment. Follow-up, three months after the procedure
revealed complete occlusion and no clinical or sonographical
complications.4. Discussion
Postcatheterization injury to the access artery is one of the
commonest iatrogenic complications inflicted by modern
medicine. It is agreed that themore complex the preceding in-
vasive procedures, the higher the incidence. They occur more
often in elderly hypertensive patients with calcified arteries,
in anti-coagulated patients, and when improper techniques
are used.10,11 According to most reports, pseudoaneurysms
occur in approximately 0.05–1.2% of all invasive arterial proce-
dures.20 The increased incidence today can be attributed to
the use of larger caliber catheters and the greater enthusiasm
for percutaneous coronary and peripheral endovascular pro-
cedures. The wide use of potent antithrombotic and anticoag-
ulant therapy is also a causative factor. The low incidence of
pseudoaneurysms in our study (0.35%) is most likely related
to the fact that most coronary procedures and peripheral an-
giograms performed at our hospital during the first two years
of the study were diagnostic rather than therapeutic proce-
dures, and all invasive procedures were performed by senior
consultants. The young age of our patients may also contrib-
ute to this low incidence. Untreated FAP can result in expan-
sion, leakage, rupture, embolization, or compression of
adjacent structures.1,2,11,21
Diagnosis of FAPs was achieved with Doppler US, which
was performed by our radiologist. CT-angiogram was not
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low the inguinal ligaments. However CT-angiography might
be needed in those doubtful cases or in those FAP which are
proximal to the ligament that always make the echographic
diagnosis problematic. In fact, CT-angiography could also
give some information about the type of access to be used if
surgery is needed.
Several therapeutic strategies have been developed to treat
this complication. They include surgical repair, ultrasound-
guided compression repair, and minimally invasive percuta-
neous treatments (thrombin injection, coil embolization and
insertion of covered stents).3 Operative repair has been the
traditional treatment, especially for those pseudoaneurysms
that are actively bleeding, are infected, orwhen serious under-
lying arterial thrombotic complications have occurred. While
repair can be simple and straightforward, complications can
occur, with the majority due to wound infection.16 A 30% inci-
dence of femoral neuralgia, and 3.7% mortality rate have also
been reported with operative repair of FAP.13,22 In our cases,
only one patient developed post surgical repair wound
infection.
Color flow duplex-guided compression obliteration has be-
come the first-line treatment of pseudoaneurysms at many
institutions.12,13,23 It has been shown to be a safe and cost-ef-
fective method for achieving pseudoaneurysm thrombosis.7,9
However, it has considerable drawbacks including long proce-
dure time, discomfort to patients, a relatively high recurrence
rate in patients receiving anticoagulant therapy, and less suc-
cessful in patients with large FAP.3,4,15 Our patients tolerated
compression thrombosis without difficulty, two patients
only required local anesthesia for pain control during duplex
compression. Contraindications for compression therapy in-
clude limb ischemia, local ischemic skin necrosis, compro-
mised runoff vessels, suspicion of infection or groin abscess,
and inaccessible site.12,14
Untreated pseudoaneurysms presenting for longer than
one month are thought to be resistant to compression throm-
bosis, perhaps due to endothelialization of the connecting
track. The higher pressure required for compression of this
track can lead to compromised flow or thrombosis of the fem-
oral vessel.12 Concurrent anticoagulation may prolong efforts
to produce thrombosis, but is not a contraindication to
attempted duplex-guided compression.23 Duplex-guided
compression of FAP, when applied appropriately has a low
complication rate. There were no complications in our series.
The natural history of FAP following invasive arterial pro-
cedures suggests that small ones may spontaneously resolve
without intervention.2,24,25 The mean duration prior to spon-
taneous thrombosis was as long as four to six weeks in indi-
viduals undergoing spontaneous thrombosis. Spontaneous
thrombosis occurred in four of our patients within three
weeks. However, to assure that these femoral injuries resolve,
follow-up color-duplex analysis was performed.
Numerous studies indicated that the percutaneous injec-
tion of thrombin with US guidance is more effective than
US-guided compression repair for the treatment of iatrogenic
FAP.3,13,15,18,23 It waswell demonstrated that direct injection of
thrombin into the sac of such false aneurysms initiates
a thrombotic process that obliterates the false aneurysm, so
that the compression becomes unnecessary.18,23,26 In manyinstitutions, sonographically guided thrombin injection has
replaced compression repair.19,26,27 This procedure appears
to be as safe as US-guided compression repair. Lonn et al.
reported that ultrasound-guided thrombin injection induces
a fast, effective, and safe thrombosis of postcatheterization
pseudoaneurysms, and they suggested that this technique is
superior to compression treatment and is recommended as
the therapy of choice.28,29 Thrombin injection may be given
in pseudoaneurysms located above the inguinal ligament,
which are contraindicated for compression because of the
theoretic risk of intraperitoneal or extraperitoneal rup-
ture.15,18,26 Perhaps the biggest advantage of the thrombin in-
jection technique is that the success rate reported in the
literature has been consistently high, at an average of 97%,
and it can usually be completed within several min-
utes.3,4,13,23,26 Furthermore, the discomfort caused by the pro-
cedure is usually limited due to single skin puncture, and the
injection itself is painless. In accordance with these facts, no
conscious sedation is required.
While the thrombin injection technique has proved to be
relatively easy to perform and appears to be suitable for
most patients with iatrogenic FAP, there are some scenarios
in which an alternative technique may be more appropriate.
It seems that pseudoaneurysms with short and wide necks
would be at higher risk of downstream embolization than
ones with long and thin necks.27,30 The possibility of down-
stream embolization emphasizes the necessity of vascular
radiology and surgical coverage when these procedures are
performed.28–30 In addition, some tiny pseudoaneurysms,
particularly if deeply located, may be too small to accurately
puncture with a needle.13,28 In this scenario, an alternative
treatment such as compression repair or waiting for sponta-
neous thrombosis seems most prudent.23,28,31 On the other
hand, it has been reported that although percutaneous
thrombin guided injection was more effective than duplex-
guided compression and less complications were reported
with thrombin injection, there was no statistically signifi-
cant difference in the length of hospital stay between the
two procedures.5,28,29 A pragmatic approach may be to use
duplex-guided compression as first-line treatment for pseu-
doaneurysms, reserving thrombin injection for failure of
the procedure, and for larger pseudoaneurysms.23 These
techniques are reserved for the stable iatrogenic FAP.
Prompt surgical repair is mandated in pseudoaneurysms as-
sociated with active thigh bleeding from rupture, skin ische-
mia, nerve compression, threatened extremity, or infection,
and in patients with a pseudoaneurysm with a wide
‘‘neck’’.4,5,11 Other nonoperative methods of treating pseu-
doaneurysms include placement of covered stents/endolu-
minal prostheses, injection of purified bovine collagen, and
percutaneous injection of fibrin adhesive.3,4,15,18
Prevention can be achieved by proper puncture tech-
nique, site selection, and by correct post-procedure hemo-
static compression with or without an external device.32
Dedicated devices are under development to enable percu-
taneous sealing of the arterial puncture site by the end of
the procedure, and some of them are already in the market.
Further development of such devices may ultimately result
in a significant decline in the rate of postcatheterization
bleeding complications.32,33
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analysis, our data suggest that both duplex-guided compres-
sion and percutaneous thrombin injection are safe and suc-
cessful, but the latter is more efficient and more
comfortable. Once a FAP has thrombosed, it remains throm-
bosed, thus obviating the need for repeated follow-up
examination.
When one considers all of the alternative treatments de-
scribed in the literature, the numerous advantages reported
– namely, high success rates, low complication rates, ease of
performance, short procedure times, and no radiation expo-
sure – favor the use of US-guided thrombin injection as the
treatment of choice for treating FAPs. The complication rate
with this technique was strikingly low. No cases of limb-
threatening ischemia were reported following thrombin injec-
tion of FAPs. Surgery is the standard method of treatment,
which can be performed under local anesthesia. Surgery is
the mainstay of treatment based on its rapidity, definitive re-
sults and rapidity of the recovery. But, surgery is associated
with the risk of complications such as hemorrhage and groin
infection and a cutaneous scar remains for life. Implantation
of covered stents into the common femoral artery is still under
clinical investigation and is not suitable for all cases, espe-
cially for lesions at the femoral arterial bifurcation.5. Conclusion
Numerous suitable options exist for the treatment of FAP, and
these include duplex-guided compression, thrombin guided
injection, and surgery. Small size pseudoaneurysms may be
observed. Biodegradable material injection and endovascular
stenting are also valid options. Duplex-guided compression,
if performed correctly, results in a high success rate with no
complications. Ultrasound-guided injection of thrombin re-
mains a very appealing treatment to most physicians due to
the procedural simplicity. Prevention can be achieved by
proper puncture technique, and correct post-procedure he-
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